Stay in the Know
Get the latest news on exciting speakers, workshops & learning opportunities at ICNMD 2021.
![]() |
Gene Therapies for Neuromuscular Disorders
For more details, see here. |
![]() 16:00 - 17:00 CET |
Complement Activation in Neurological Diseases: From the Central Nervous System to the Neuromuscular Junction Chair: Dr. Angela Genge
For more details, see here. |
![]() 13:00 - 14:00 CET |
New Insights in the Use of Intravenous Immunoglobulins: How to Enhance CIDP Patients' Clinical Outcomes? Chair: Eduardo Nobile-Orazio
For more details, see here. |
![]() 16:00 - 17:00 CET |
Pompe Disease: Neuromuscular and Respiratory Manifestations
For more details, see here. |
![]() 13:00 - 14:00 CET |
Optimising Patient Care Across the Evolving SMA Landscape Chair: Dr. Nathalie Goemans, Neuromuscular Reference Centre for Children, University Hospitals, Leuven, Belgium
For more details, see here. |
![]() 16:00 - 17:00 CET |
Advancing the Management of Duchenne Muscular Dystrophy: the Role of Real-World Evidence Chair: Professor Juan Vilchez, Valencia, Spain
For more details, see here. |
![]() 13:00 - 14:00 CET |
Time to SHINE on SMA: Exploring the Evidence from SHINE, the Nusinersen Open-Label Extension Study in Infants and Children
For more details, see here. |
![]() 16:00 - 17:00 CET |
Past, Present and Future: Realizing the Potential of Gene Therapy for Neuromuscular Disorders Chair: Dr Eduardo Tizzano
For more details, see here. |
The above-listed Virtual Industry-Supported Symposia will be aired “live” during ICNMDigital at the time listed, then available on-demand on the Virtual Library until ICNMD 2021 in Valencia.
In addition, the following symposium will also be available on-demand on the Virtual Library, after ICNMDigital has concluded.
Virtual Industry-Supported Symposium supported by UCB Biopharma
Myasthenia Gravis: Patient and Clinician Perspective
Chair: Prof. Pushpa Narayanaswami, USA